CRC
NVO

Curi RMB Capital’s Novo Nordisk NVO Stock Holding History

Curi RMB Capital’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$360K Buy
9,807
+322
+3% +$15.3K 0.01% 686
2025
Q4 		$483K Buy
9,485
+211
+2% +$10.8K 0.01% 625
2025
Q3 		$515K Sell
9,274
-1,779
-16% -$104K 0.01% 510
2025
Q2 		$763K Sell
11,053
-40,093
-78% -$2.73M 0.01% 453
2025
Q1 		$3.6M Buy
51,146
+39,514
+340% +$3.26M 0.09% 218
2024
Q4 		$1M Sell
11,632
-1,464
-11% -$158K 0.02% 336
2024
Q3 		$1.56M Sell
13,096
-192
-1% -$25.6K 0.04% 298
2024
Q2 		$1.9M Buy
13,288
+1,685
+15% +$223K 0.05% 266
2024
Q1 		$1.49M Buy
11,603
+1,915
+20% +$228K 0.03% 303
2023
Q4 		$1M Buy
9,688
+1,442
+17% +$143K 0.03% 290
2023
Q3 		$750K Buy
8,246
+434
+6% +$38.2K 0.03% 317
2023
Q2 		$632K Sell
7,812
-284
-4% -$23.2K 0.02% 345
2023
Q1 		$644K Sell
8,096
-390
-5% -$27.7K 0.02% 334
2022
Q4 		$574K Buy
8,486
+2,672
+46% +$157K 0.02% 343
2022
Q3 		$290K Buy
5,814
+190
+3% +$10.2K 0.01% 408
2022
Q2 		$313K Hold
5,624
– – 0.01% 405
2022
Q1 		$312K Hold
5,624
– – 0.01% 383
2021
Q4 		$315K Hold
5,624
– – 0.01% 395
2021
Q3 		$270K Hold
5,624
– – 0.01% 405
2021
Q2 		$236K Sell
5,624
-2,566
-31% -$99.5K 0.01% 437
2021
Q1 		$276K Sell
8,190
-2,530
-24% -$90.1K 0.01% 408
2020
Q4 		$374K Sell
10,720
-16
-0.1% -$553 0.01% 471
2020
Q3 		$373K Buy
10,736
+16
+0.1% +$533 0.02% 464
2020
Q2 		$351K Sell
10,720
-2,516
-19% -$80.3K 0.02% 457
2020
Q1 		$399K Buy
13,236
+2,026
+18% +$60.3K 0.02% 433
2019
Q4 		$325K Sell
11,210
-898
-7% -$24.9K 0.01% 531
2019
Q3 		$313K Hold
12,108
– – 0.01% 573
2019
Q2 		$309K Sell
12,108
-204
-2% -$5.04K 0.01% 627
2019
Q1 		$322K Sell
12,312
-2,122
-15% -$52.2K 0.01% 656
2018
Q4 		$333K Sell
14,434
-52
-0.4% -$1.16K 0.01% 721
2018
Q3 		$341K Sell
14,486
-3,724
-20% -$90.9K 0.01% 702
2018
Q2 		$420K Buy
18,210
+3,884
+27% +$92.3K 0.01% 656
2018
Q1 		$352K Sell
14,326
-136
-0.9% -$3.57K 0.01% 691
2017
Q4 		$389K Buy
+14,462
New +$368K 0.01% 659
2014
Q4 		– Sell
-8,562
Closed -$204K – 452
2014
Q3 		$204K Sell
8,562
-386
-4% -$8.88K 0.01% 420
2014
Q2 		$207K Sell
8,948
-3,596
-29% -$79.4K 0.01% 404
2014
Q1 		$287K Sell
12,544
-4,506
-26% -$96K 0.02% 312
2013
Q4 		$315K Sell
17,050
-2,860
-14% -$49.8K 0.02% 284
2013
Q3 		$337K Sell
19,910
-6,400
-24% -$108K 0.02% 284
2013
Q2 		$408K Buy
+26,310
New +$438K 0.03% 257

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Curi RMB Capital's NVO Position: Q1 2026 in Review

Curi RMB Capital increased its Novo Nordisk (NVO) stake by 3.4% in Q1 2026, buying an estimated $15.3K and bringing the position to 9,807 shares worth $360K. The position accounts for 0.01% of the portfolio, ranked #686.

Curi RMB Capital first reported a position in NVO in Q2 2013 and has held it in 40 quarters since. The position peaked at $3.6M in Q1 2025. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Curi RMB Capital held 9,807 shares of Novo Nordisk worth $360K as of Q1 2026.
  • Curi RMB Capital bought 322 Novo Nordisk shares in Q1 2026, an estimated $15.3K.
  • Novo Nordisk made up 0.01% of Curi RMB Capital's portfolio in Q1 2026, its #686 holding.
  • Curi RMB Capital first reported a position in Novo Nordisk in Q2 2013 and has held it in 40 quarters since.
  • Curi RMB Capital's Novo Nordisk position peaked at $3.6M in Q1 2025.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Curi RMB Capital's 13F filing for Q1 2026, filed 15 May 2026.